India Takes Steps to Control Flood of Unapproved FDC Products

International Pharmaceutical Regulatory Monitor
A A
An advisory panel to India’s Central Drugs Standard Control Organization is calling for guidelines on the verification of fixed-dose combination drug products that are currently being sold without marketing authorization.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00